Sign up to save your podcasts
Or
Share 302: Vertex's big deal, biotech's red numbers, & an industry history lesson
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
302: Vertex's big deal, biotech's red numbers, & an industry history lesson
How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss a multibillion-dollar deal from Vertex Pharmaceuticals with sweeping implications and a lengthy backstory. We also explain why gas prices are weighing on biotech, and make a surprise announcement.
View all episodes
By STAT
4.5
309309 ratings
How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss a multibillion-dollar deal from Vertex Pharmaceuticals with sweeping implications and a lengthy backstory. We also explain why gas prices are weighing on biotech, and make a surprise announcement.
More shows like The Readout Loud
View all
Planet Money
30,678 Listeners
Odd Lots
1,896 Listeners
What the Health? From KFF Health News
499 Listeners
The Indicator from Planet Money
9,513 Listeners
The Journal.
6,086 Listeners
Tradeoffs
394 Listeners
Biotech 2050 Podcast
61 Listeners
Business Of Biotech
86 Listeners
BioCentury This Week
34 Listeners
Dwarkesh Podcast
505 Listeners
Hard Fork
5,473 Listeners
Biotech Hangout
19 Listeners
Ground Truths
48 Listeners
Money Stuff: The Podcast
387 Listeners
The BioCentury Show
12 Listeners